Skip to main content
Tanaffos logoLink to Tanaffos
. 2021 Jan;20(1):36–42.

Assessment of Quality of Life and the Risk of Obstructive Sleep Apnea in Individuals with Chronic Rhinosinusitis who are Candidate for Functional Endoscopic Sinus Surgery

Jahangir Ghorbani 1, Shahabeddin Goudarzi 2, Parisa Adimi Naghan 3, Afshin Nikravesh 2, Somayeh Akhavan 1, Alireza Afshar 4, Payam Abbasi 1,5,
PMCID: PMC8355935  PMID: 34394368

Abstract

Background:

Chronic rhinosinusitis is associated with changes in quality of life (QoL). The present study intended to evaluate the QoL and risk of obstructive sleep apnea in individuals with chronic rhinosinusitis who were candidate for functional endoscopic sinus surgery. To determine the Quality of Life and the risk of sleep apnea in cases with chronic Rhinosinusitis.

Materials and Methods:

A total of 100 patients with drug-resistant chronic rhinosinusitis candidate for functional endoscopic sinus surgery referred to the ENT clinic of Masih Daneshvari Hospital, Tehran, Iran were recruited. SNOT-22 and STOP-BANG questionnaires were filled before the surgery.

Results:

The mean SNOT-22 score was 40.44, with a standard deviation of 19.27 (ranged from 1 to 94). Also, according to the STOP-BANG questionnaire, 62% of participants were at increased risk of OSA. Based on the cut-off point of 30 for the SNOT-22 score (either larger or lower than 30), patients were categorized into two groups. Sixty-eight percent of participants were categorized in ≥ 30 SNOT-22 score. Age below 50, female gender, and those at high risk of OSA were associated with lower QoL.

Conclusion:

Most patients with chronic rhinosinusitis had a low QoL and were mostly at increased risk of OSA. Being women younger than 50 years and the presence of OSA probably are associated with lower QoL in these patients.

Keywords: Quality of life, endoscopic sinus surgery, rhinosinusitis, sleep apnea

INTRODUCTION

Rhinosinusitis is characterized by inflammation in the nasal mucosa and paranasal sinuses. The term “chronic” refers to rhinosinusitis, where the paranasal sinus inflammation lasts for at least 12 consecutive weeks (1). According to the estimates, depending on the country, its prevalence ranges from 12 to 15% (2). Chronic rhinosinusitis (CRS) is a multifactorial disease whose definite pathophysiology mechanism has not yet been recognized. Factors that effectively contribute to CRS development can be categorized as either patient-related or environmental factors (3). Allergy, genetic predisposition, disorders of mucociliary clearance, anatomical causes, and gastroesophageal reflux disease are considered as patient-related factors. Also, environmental factors include infectious-related factors such as viral and fungal infections, trauma, cigarette smoking, and environmental pollutants (35). A series of clinical criteria are developed for CRS diagnosis. However, to confirm the final diagnosis, clinical findings must be approved by an objective tool such as the CT scan or endoscopy (6). In addition to clinical symptoms, endoscopy findings, including polyp, secretions, changed mucosal color, and edema presence in the middle meatus, are considered as objective criteria (7). Although various tools are available for the evaluation of negative effects of some diseases on normal life and the success rate of therapeutic interventions, those developed for evaluation of the quality of life (QoL) have crucial importance (8, 9). In recent years, several tools intended to investigate the QoL of patients with CRS have been introduced. For instance, a 22-item sino-nasal outcome test (SNOT-22) is a specific questionnaire intended to evaluate the QoL of patients with sino-nasal problems like CRS. Apart from the nose and sinuses, this tool contains items related to the ear, sleep, general health, and emotions (10). The SNOT contains at least 4 items on sleep. Hence, the current study intended to evaluate the risk of obstructive sleep apnea in CRS patients scheduled for sinus surgery and its association with SNOT-22 measures of QoL using the STOP questionnaire. This is an easy and sensitive tool to diagnose patients at high risk of OSA (11). While a few studies evaluated the QoL and sleep apnea risk in patients with CRS simultaneously, we decided to report the impact of CRS on QoL of patients and its association with the risk of OSA in patients referred to our referral center.

MATERIALS AND METHODS

This is a descriptive, cross-sectional and analytical study designed to determine and compare the quality of life and apnea risk rate in patients with chronic sinusitis. Informed consent was obtained from all participants. In addition, the Ethics Committee of Shahid Beheshti University of Medical Sciences, Tehran, Iran, approved the current study.

Patients

This study was performed in a university hospital in Tehran, Iran. Patients with CRS resistance to 1-month standard medical treatment who were candidate for endoscopic sinus surgery above 15 years old entered the study. Patients with a history of sinus surgery, cystic fibrosis, or ciliary dyskinesia were excluded. All patients filled the SONT and STOP questionnaires.

Scoring method of SNOT questionnaire

We used the validated Persian version of SNOT-22 presented by Jalessi et al. (11). SNOT-22 questionnaire is scored on a six-point Likert scale, ranging from zero (“no problem”) to five (“most severe problems”). The final score is equal to the sum of scores related to all items, which ranges from zero to 110. The higher the score, the more severe is the disease and its associated disability, which indicates more negative impacts on the QoL.

Determination of risk rate of obstructive sleep apnea (OSA) by STOP questionnaire

The STOP questionnaire is designed by Chung et al. to screen patients for OSA before surgery (12). It contains both objective and subjective items (13). Its sensitivity for the identification of OSA ranges from 94 to 97%. The Persian version of this questionnaire is reported by 14. Sadeghniiat-Haghighi et al., who reported a sensitivity of 91% compared to the apnea index in polysomnography (14). The STOP-BANG questionnaire includes eight items on the history of loud snore, tiredness during the day, apnea, hypertension, body mass index (BMI), age, neck circumference, and gender.

STOP-BANG questionnaire scoring

Each positive answer has a positive point. Its total score ranges from zero to 8. A score of three or higher (out of 8) indicate a high risk of OSA.

Statistical analysis

Data analysis was administered using SPSS version 22 by Chi-square, Fisher, independent t-test, ANOVA, and univariate and multivariate logistic regression models.

RESULTS

Demographic characteristics

A total of 100 patients (67 males and 33 females) with CRS who were candidates for FESS were included in this study. The mean age of participants was 39.5±13.8 years. The youngest and oldest participants were 15 and 86 years old, respectively. The mean BMI was 26.2±5.3 and 33% of them had a BMI higher than 30. Other information are provided in Table 1.

Table 1.

Characteristics of patients with chronic rhinosinusitis in this study

Variable SD /Mean
Volume (Percent)
Age Less than 50 years old 80 (80%)
More than 50 years old 20 (20%)
Numerical Age 39.5 ± 13.8
Sex Woman 33 (33%)
Men 67 (67%)
Body Mass Index
(BMI)
Less than 18.5 3 (3%)
18.5 Up to 25 41 (41%)
25 Up to 30 33 (33%)
More than 30 23 (23%)
Numerical Index 26.2 ± 5.3
Hypertension Yes 11 (11%)
No 89 (89%)

Association between the quality of life score and chronic rhinosinusitis, calculated using SNOT-22 questionnaire

The mean score of the SNOT-22 was 40.8 ± 19.3 (Table 2), which for 68% of patients was higher than 30. On the other hand, about, 40% of participants had a score between 30 and 50 (Figure 1).

Table 2.

Quality of life scores associated with chronic rhinosinusitis from the SNOT-22 questionnaire

Variable SD /Mean Median (Min-max) Volume (Percent)
Questionnaire score (quantity) 40.8 ± 19.3 38 (1–94) -
Questionnaire (quality) Less than 30 - - 32 (32%)
More or equal to 30 - - 68 (68%)

Figure 1.

Figure 1.

SNOT-22 score. Frequency of participants in ten categories of questionnaires scores

OSA Risk

According to findings obtained from the STOP-BANG questionnaire, 62% of patients were at increased risk of OSA (at least 3) (Table 3). Also, the SNOT-22 score was examined by the separation of underlying variables that were not significantly different between the study groups (based on gender, age, BMI, and OSA) (Table 4). Hence, we performed logistic regression to consider the effect of different variables.

Table 3.

The frequency of sleep apnea risk

Variable SD /Mean Volume (Percent)
STOP-BANG Questionnaire score 3.2 ± 1.7
OSA No 38 (38%)
Yes 62 (62%)

Table 4.

SNOT-22 score by gender, body mass index, age and status of the OSA

Variable Mean(SD) P-Value
Age Less than 50 years old 47 (19) 0.242
More than 50 years old 41 (20)
Sex Woman 45 (19.6) 0.959
Man 46 (19.5)
Body Mass Index (BMI) Less than 25 40.7 (21) 0.641
Between 25 to 30 43 (18.1)
Over 30 38 (17.9)
OSA Yes 48 (19) 0.086
No 41 (20)

Since a SNOT-22 score of > 30 corresponds with a low level of QoL and the effect of FESS on the improvement of their QoL was higher (15), in the present study, the score of 30 was considered as a cut point for SNOT-22.

Logistic regression

The interaction between the effects of independent variables such as age, sex, BMI, and OSA as well as CRS on patient’s QoL was investigated by utilization of straightforward and multiple models of logistic regression. Based on the findings of the Hopkins study (14), a score of 30 was considered as the cut-off point. Then, based on the cut point, patients were divided into two groups of low QoL (score≥30) and relatively optimum QoL (score<30). All variables were analyzed using a single-variable logistic model (Table 5). To investigate the effect of each variable in the presence of other variables (controlling for other variables), all of the following variables were entered into the multivariate logistic model: age, gender, BMI, and OSA. In the present study, multiple logistical model was utilized to model the included variables. It is worth noting that variables with a considerable effect on the QoL associated with rhinosinusitis included age, gender, and OSA.

Table 5.

The effect of different independent variables on the quality of life score of patients with chronic rhinosinusitis in a simple and multiple regression models.

Independent Variable Odd ratio
(P-value: 95%)
P- Value Adjusted ratio
(P-value: 95%)
P- Value
Age
(Age <50 to Age ≥50)
2.64 (0.97–7.2) 0.059 3.86 (1.25–11.9) *0.019
Sex
(Women/Men)
1.74 (0.68–4.5) 0.246 3.4 (1.01–11.8) *0.048
Body Mass Index
(<25 to ≥25)
1.72 (0.74–4) 0.209 1.57 (0.59–4.2) 0.363
OSA
Patients/ Healthy people
1.43 (0.61–3.4) 0.417 3.5 (0.98–12.7) 0.054

Age

According to results obtained from the final model, the adjusted odds ratios, after controlling for other variables, were considered. A patient, younger than 50 years in comparison to a patient older than 50 years, has an odds ratio (OR) of 3.86% for a “lower level of QoL associated with CRS”(p=0.019).

Gender

After eliminating the effect of other variables, women were 3.4 times more likely than men to have a low level of QoL associated with CRS. Also, the raw value ratio of the gender variable odds was 1.74 in the univariate model. Due to the significant difference with the adjusted value, it can be argued that the effect of gender is distorted by the effect of other variables (p=0.048).

OSA

The adjusted OR of OSA for the QoL associated with CRS was 3.5, which was not statistically significant (p=0.054). As the obtained upper quartile of the confidence interval was large, the OR of this variable is probably due to the low number of subjects in the non-OSA group, which probably has led to the problem of data-sparse and low accuracy of the estimates.

DISCUSSION

This study aimed to determine, firstly, the QoL associated with the health of people with CRS who were candidate for FESS, using the SNOT-22 questionnaire, and, secondly, to investigate the risk of OSA in these individuals using the STOP-BANG tool. According to the findings, these patients often suffer from low QoL and are mostly at increased risk of OSA. After removing the effect of confounding variables, the age below 50 and the female gender were significantly associated with lower QoL. The occurrence of OSA also had a positive association with lower QoL, although it was not statistically significant. In other words, CRS patients, both with a SNOT-22 score higher or lower than 30 (which indicates relative and low QoL, respectively), are at increased risk of OSA. It seems that CRS has a more severe negative impact on women younger than 50 years.

In Iran, a few studies have investigated the QoL associated with rhinosinusitis. In a recent prospective study, Aghdas et al. showed that the mean score of SNOT-22 was 59.38±5.84 in CRS patients, which is higher than the value reported in the present study (16). This imbalance can be due to the higher prevalence of polyps in these patients. In two other studies conducted in other countries by Steel and Hopkins, the mean score of the SNOT-22 is reported as 75.5 and 40.9, respectively (17, 18). All these studies reported low QoL in patients and also based on their findings, the score of QoL was improved remarkably after the surgery (1921). Some studies reported an association between CRS and sleep and emotional problems. For instance, according to the findings of a large Swedish study, sleep problems were frequent among patients with rhinosinusitis and reported a relation between prevalence of sleep problems and severity of CRS (22). Brandsted et al. demonstrated that 25% of CRS patients have recently been treated for depression that is more than the average for depression in the general population (10–16%). According to their findings, CRS patients with depression had a lower score of health-related quality of life (HRQoL) and also lower QoL compared to CRS patients without depression (23). In addition to the higher rate of depression in the CRS population, high rates of anxiety disorders have been reported in these patients (24). It can be concluded that depression and anxiety are commonly associated with CRS and declined HRQoL in these patients. Although depression and CRS independently cause decreased HRQoL, healthcare professionals should be aware of the high rate of depression in these patients and the probable consequences of inappropriate case management. Future studies are needed to determine whether depression treatment simultaneously can improve HRQoL in patients with CRS or not. Persistent symptoms in association with CRS not only can disrupt vitality but also may affect other essential activities such as sleep and sexual activity. Benninger et al. (2010) demonstrated that patients with CRS suffer from significantly lower sleep quality and sexual activity (25). Fatigue and fibromyalgia are commonly associated with CRS, and it has recently been shown that both of them were improved following endoscopic sinus surgery (26). Other studies showed that CRS treatment has beneficial effects on these abnormalities and could improve HRQoL (27). For instance, a systematic review and meta-analysis by Chester et al. confirmed the improvement of fatigue following endoscopic sinus surgery (28).

According to our results, a high percentage of patients with CRS are at increased risk of sleep apnea, which is in line with the findings of some previous studies. In a study on 534 participants,

Weintraub et al. investigated the association between CRS and OSA and reported a higher frequency of OSA in patients with CRS. They also mentioned CRS patients as a risk factor for OSA, regardless of age and BMI (29). Various studies reported different prevalence rates for OSA, which can be attributed to the characteristics of the study population. In the present study, the QoL of patients with OSA was slightly lower than those without OSA. Previously, the simultaneous effects of CRS and OSA on the QoL associated with rhinosinusitis have been studied. In a study on 405 patients with CRS, who were candidates for FESS, 15% of participants had concurrent OSA. Also, patients with rhinosinusitis and OSA have lower QoL than OSA patients without rhinosinusitis. However, there was a significant improvement in the QoL of both groups after sinus surgery (30). Craig also indicated lower QoL associated with sleep impairment in patients with rhinitis, rhinosinusitis, and nasal polyposis (31). Furthermore, Lachanas et al. have compared patients with CRS and patients with OSA concerning their QoL using the SNOT-20 questionnaire. According to their findings, the mean SNOT-20 score was high in both CRS and OSA groups but the pattern of symptoms distribution was different. In other words, OSA patients had higher scores for the wellness dimension, while CRS patients had a higher score for posterior sinonasal symptoms (32). Sleep problems in CRS patients can be attributed to several factors, including inflammation and nasal obstruction (22).

Considering the high frequency of probable OSA in patients with CRS (based on the STOP-BANG questionnaire), a series of questions about sleep quality and the consequences of sleep apnea should be answered. Many patients with CRS may not be aware of their sleep problems. Hence, direct and specific questions related to OSA should be considered in pre- and post-operative consultations. It seems that patients at high risk of OSA have worse QoL.

In the present study, QoL and the risk of OS in CRS patients before FESS were investigated. Future studies should evaluate changes in QoL and risk of OSA following receiving different treatment modalities, particularly using polysomnography.

CONCLUSION

This study demonstrated that most patients with chronic rhinosinusitis had a low quality of life, and most of them are at increased risk of OSA. Being younger than 50 years, gender female, and OSA are probably associated with lower quality of life. Considering the high probability of OSA in CRS patients, screening is recommended for timely diagnosis and treatment.

REFERENCES

  • 1.Desrosiers M, Evans GA, Keith PK, Wright ED, Kaplan A, Bouchard J, et al. Canadian clinical practice guidelines for acute and chronic rhinosinusitis. Allergy Asthma Clin Immunol 2011;7(1):2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.DeConde AS, Soler ZM. Chronic rhinosinusitis: Epidemiology and burden of disease. Am J Rhinol Allergy 2016;30(2):134–9. [DOI] [PubMed] [Google Scholar]
  • 3.Lee S, Lane AP. Chronic rhinosinusitis as a multifactorial inflammatory disorder. Curr Infect Dis Rep 2011;13(2):159–68. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4.Benninger MS, Ferguson BJ, Hadley JA, Hamilos DL, Jacobs M, Kennedy DW, et al. Adult chronic rhinosinusitis: definitions, diagnosis, epidemiology, and pathophysiology. Otolaryngol Head Neck Surg 2003;129(3 Suppl):S1–32. [DOI] [PubMed] [Google Scholar]
  • 5.Skoner DP. Allergic rhinitis: definition, epidemiology, pathophysiology, detection, and diagnosis. J Allergy Clin Immunol 2001;108(1 Suppl):S2–8. [DOI] [PubMed] [Google Scholar]
  • 6.Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, Brook I, Ashok Kumar K, Kramper M, et al. Clinical practice guideline (update): adult sinusitis. Otolaryngol Head Neck Surg 2015;152(2 Suppl):S1–S39. [DOI] [PubMed] [Google Scholar]
  • 7.Stankiewicz JA, Chow JM. Nasal endoscopy and the definition and diagnosis of chronic rhinosinusitis. Otolaryngol Head Neck Surg 2002;126(6):623–7. [DOI] [PubMed] [Google Scholar]
  • 8.van Oene CM, van Reij EJ, Sprangers MA, Fokkens WJ. Quality-assessment of disease-specific quality of life questionnaires for rhinitis and rhinosinusitis: a systematic review. Allergy 2007;62(12):1359–71. [DOI] [PubMed] [Google Scholar]
  • 9.Birch DS, Saleh HA, Wodehouse T, Simpson IN, Mackay IS. Assessing the quality of life for patients with chronic rhinosinusitis using the “Rhinosinusitis Disability Index”. Rhinology 2001;39(4):191–6. [PubMed] [Google Scholar]
  • 10.DeConde AS, Mace JC, Bodner T, Hwang PH, Rudmik L, Soler ZM, et al. SNOT-22 quality of life domains differentially predict treatment modality selection in chronic rhinosinusitis. Int Forum Allergy Rhinol 2014;4(12):972–9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Jalessi M, Farhadi M, Kamrava SK, Amintehran E, Asghari A, Rezaei Hemami M, et al. The reliability and validity of the persian version of sinonasal outcome test 22 (snot 22) questionnaires. Iran Red Crescent Med J 2013;15(5):404–8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chung F, Yegneswaran B, Liao P, Chung SA, Vairavanathan S, Islam S, et al. STOP questionnaire: a tool to screen patients for obstructive sleep apnea. Anesthesiology 2008;108(5):812–21. [DOI] [PubMed] [Google Scholar]
  • 13.Silva GE, Vana KD, Goodwin JL, Sherrill DL, Quan SF. Identification of patients with sleep disordered breathing: comparing the four-variable screening tool, STOP, STOP-Bang, and Epworth Sleepiness Scales. J Clin Sleep Med 2011;7(5): 467–72. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Sadeghniiat-Haghighi K, Montazeri A, Khajeh-Mehrizi A, Ghajarzadeh M, Alemohammad ZB, Aminian O, et al. The STOP-BANG questionnaire: reliability and validity of the Persian version in sleep clinic population. Qual Life Res 2015;24(8):2025–30. [DOI] [PubMed] [Google Scholar]
  • 15.Hopkins C, Slack R, Lund V, Brown P, Copley L, Browne J. Long-term outcomes from the English national comparative audit of surgery for nasal polyposis and chronic rhinosinusitis. Laryngoscope 2009;119(12):2459–65. [DOI] [PubMed] [Google Scholar]
  • 16.Aghdas MM, Shahidi N, Sheikhzadeh D, Ebrahimzadeh M. Quality of Life in Patients with Chronic Rhinosinusitis with Nasal Polyposis Before and After Functional Endoscopic Sinus Surgery: A Study Based on SINO-NASAL OUTCOME TEST. Advances in Bioscience and Clinical Medicine 2018;6(1):11–4. [Google Scholar]
  • 17.Steele TO, Rudmik L, Mace JC, DeConde AS, Alt JA, Smith TL. Patient-centered decision making: the role of the baseline SNOT-22 in predicting outcomes for medical management of chronic rhinosinusitis. Int Forum Allergy Rhinol 2016;6(6): 590–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hopkins C, Rudmik L, Lund VJ. The predictive value of the preoperative Sinonasal Outcome Test-22 score in patients undergoing endoscopic sinus surgery for chronic rhinosinusitis. Laryngoscope 2015;125(8):1779–84. [DOI] [PubMed] [Google Scholar]
  • 19.Lange B, Holst R, Thilsing T, Baelum J, Kjeldsen A. Quality of life and associated factors in persons with chronic rhinosinusitis in the general population: a prospective questionnaire and clinical cross-sectional study. Clin Otolaryngol 2013;38(6):474–80. [DOI] [PubMed] [Google Scholar]
  • 20.Rudmik L, Soler ZM, Mace JC, DeConde AS, Schlosser RJ, Smith TL. Using preoperative SNOT-22 score to inform patient decision for Endoscopic sinus surgery. Laryngoscope 2015;125(7):1517–22. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21.Abdalla S, Alreefy H, Hopkins C. Prevalence of sinonasal outcome test (SNOT-22) symptoms in patients undergoing surgery for chronic rhinosinusitis in the England and Wales National prospective audit. Clin Otolaryngol 2012;37(4):276–82. [DOI] [PubMed] [Google Scholar]
  • 22.Bengtsson C, Lindberg E, Jonsson L, Holmström M, Sundbom F, Hedner J, et al. Chronic Rhinosinusitis Impairs Sleep Quality: Results of the GA2LEN Study. Sleep 2017;40(1):1–6. [DOI] [PubMed] [Google Scholar]
  • 23.Brandsted R, Sindwani R. Impact of depression on disease-specific symptoms and quality of life in patients with chronic rhinosinusitis. Am J Rhinol 2007;21(1):50–4. [DOI] [PubMed] [Google Scholar]
  • 24.Wasan A, Fernandez E, Jamison RN, Bhattacharyya N. Association of anxiety and depression with reported disease severity in patients undergoing evaluation for chronic rhinosinusitis. Ann Otol Rhinol Laryngol 2007;116(7):491–7. [DOI] [PubMed] [Google Scholar]
  • 25.Benninger MS, Khalid AN, Benninger RM, Smith TL. Surgery for chronic rhinosinusitis may improve sleep and sexual function. Laryngoscope 2010;120(8):1696–700. [DOI] [PubMed] [Google Scholar]
  • 26.Sautter NB, Mace J, Chester AC, Smith TL. The effects of endoscopic sinus surgery on level of fatigue in patients with chronic rhinosinusitis. Am J Rhinol 2008;22(4):420–6. [DOI] [PubMed] [Google Scholar]
  • 27.Kim do H, Han K, Kim SW. Effect of Chronic Rhinosinusitis With or Without Nasal Polyp on Quality of Life in South Korea: 5th Korea National Health and Nutrition Examination Survey Korean. Clin Exp Otorhinolaryngol 2016;9(2):150–6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Chester AC, Sindwani R, Smith TL, Bhattacharyya N. Fatigue improvement following endoscopic sinus surgery: a systematic review and meta-analysis. Laryngoscope 2008;118(4):730–9. [DOI] [PubMed] [Google Scholar]
  • 29.Weintraub MA, Sunderram J, Kipen H, Laumbach RJ, Udasin I, Lu SE, et al. Chronic RhINOSinusitis Is An Independent Risk Factor For Obstructive Sleep Apnea In World Trade Center Responders. In D30. New Insights into Obstructive Sleep Apnea Pathogenesis 2017; A7274–A7274. [Google Scholar]
  • 30.Alt JA, DeConde AS, Mace JC, Steele TO, Orlandi RR, Smith TL. Quality of Life in Patients With Chronic Rhinosinusitis and Sleep Dysfunction Undergoing Endoscopic Sinus Surgery: A Pilot Investigation of Comorbid Obstructive Sleep Apnea. JAMA Otolaryngol Head Neck Surg 2015;141(10):873–81. [DOI] [PubMed] [Google Scholar]
  • 31.Craig TJ, Ferguson BJ, Krouse JH. Sleep impairment in allergic rhinitis, rhinosinusitis, and nasal polyposis. Am J Otolaryngol 2008;29(3):209–17. [DOI] [PubMed] [Google Scholar]
  • 32.Lachanas VA, Woodard TD, Antisdel JL, Kountakis SE. Sino-nasal outcome test tool assessment in patients with chronic rhinosinusitis and obstructive sleep apnea. ORL J Otorhinolaryngol Relat Spec 2012;74(5):286–9. [DOI] [PubMed] [Google Scholar]

Articles from Tanaffos are provided here courtesy of National Research Institute of Tuberculosis and Lung Disease

RESOURCES